Literature DB >> 19294488

Layer-specific sulfatide localization in rat hippocampus middle molecular layer is revealed by nanoparticle-assisted laser desorption/ionization imaging mass spectrometry.

Hiroshi Ageta1, Sayaka Asai, Yuki Sugiura, Naoko Goto-Inoue, Nobuhiro Zaima, Mitsutoshi Setou.   

Abstract

Lipids are major structural component of the brain and play key roles in signaling functions in the central nervous system (CNS), such as the hippocampus. In particular, sulfatide is an abundant glycosphingolipid component of both the central and the peripheral nervous system and is an essential lipid component of myelin membranes. Lack of sulfatide is observed in myelin deformation and neurological deficits. Previous studies with antisulfatide antibody have investigated distribution of sulfatide expression in neurons; however, this method cannot distinguish the differences of sulfatide lipid species raised by difference of carbon-chain length in the ceramide portion in addition to the differences of sulfatide and seminolipid. In this study, we solved the problem by our recently developed nanoparticle-assisted laser desorption/ionization (nano-PALDI)-based imaging mass spectrometry (IMS). We revealed that the level of sulfatide in the middle molecular layer was significantly higher than that in granule cell layers and the inner molecular layer in the dentate gyrus of rat hippocampus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294488     DOI: 10.1007/s00795-008-0427-6

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  54 in total

1.  Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues.

Authors:  M Stoeckli; P Chaurand; D E Hallahan; R M Caprioli
Journal:  Nat Med       Date:  2001-04       Impact factor: 53.440

2.  A turn of the sulfatide in Alzheimer's disease.

Authors:  Michael C Irizarry
Journal:  Ann Neurol       Date:  2003-07       Impact factor: 10.422

3.  A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation.

Authors:  Tomoko Ishibashi; Jeffrey L Dupree; Kazuhiro Ikenaka; Yukie Hirahara; Koichi Honke; Elior Peles; Brian Popko; Kinuko Suzuki; Hitoo Nishino; Hiroko Baba
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

4.  Ceramide UDPgalactosyltransferase from myelinating rat brain: purification, cloning, and expression.

Authors:  S Schulte; W Stoffel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

5.  Accumulation of sulfatide in neuronal and glial cells of arylsulfatase A deficient mice.

Authors:  Marie Molander-Melin; Zarah Pernber; Sebastian Franken; Volkmar Gieselmann; Jan-Eric Månsson; Pam Fredman
Journal:  J Neurocytol       Date:  2004-07

6.  Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development.

Authors:  R Bansal; A E Warrington; A L Gard; B Ranscht; S E Pfeiffer
Journal:  J Neurosci Res       Date:  1989-12       Impact factor: 4.164

7.  Targeted analysis of ganglioside and sulfatide molecular species by LC/ESI-MS/MS with theoretically expanded multiple reaction monitoring.

Authors:  Kazutaka Ikeda; Takao Shimizu; Ryo Taguchi
Journal:  J Lipid Res       Date:  2008-08-14       Impact factor: 5.922

8.  Increasing sulfatide synthesis in myelin-forming cells of arylsulfatase A-deficient mice causes demyelination and neurological symptoms reminiscent of human metachromatic leukodystrophy.

Authors:  Hariharasubramanian Ramakrishnan; Kerstin Khalaj Hedayati; Renate Lüllmann-Rauch; Carsten Wessig; Simon Ngamli Fewou; Helena Maier; Hans-Hilmar Goebel; Volkmar Gieselmann; Matthias Eckhardt
Journal:  J Neurosci       Date:  2007-08-29       Impact factor: 6.167

9.  MALDI-based imaging mass spectrometry revealed abnormal distribution of phospholipids in colon cancer liver metastasis.

Authors:  Shuichi Shimma; Yuki Sugiura; Takahiro Hayasaka; Yutaka Hoshikawa; Tetsuo Noda; Mitsutoshi Setou
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-28       Impact factor: 3.205

10.  A fluorescence-based, high-throughput sphingomyelin assay for the analysis of Niemann-Pick disease and other disorders of sphingomyelin metabolism.

Authors:  Xingxuan He; Fei Chen; Margaret M McGovern; Edward H Schuchman
Journal:  Anal Biochem       Date:  2002-07-01       Impact factor: 3.365

View more
  17 in total

Review 1.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 2.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 3.  Developments and applications of mass microscopy.

Authors:  Mitsutoshi Setou; Kamlesh Shrivas; Morakot Sroyraya; Hyunjeong Yang; Yuki Sugiura; Junji Moribe; Akira Kondo; Koji Tsutsumi; Yoshishige Kimura; Nobuya Kurabe; Takahiro Hayasaka; Naoko Goto-Inoue; Nobuhiro Zaima; Koji Ikegami; Prasert Sobhon; Yoshiyuki Konishi
Journal:  Med Mol Morphol       Date:  2010-03-26       Impact factor: 2.309

Review 4.  Molecular mass spectrometry imaging in biomedical and life science research.

Authors:  Jaroslav Pól; Martin Strohalm; Vladimír Havlíček; Michael Volný
Journal:  Histochem Cell Biol       Date:  2010-10-28       Impact factor: 4.304

Review 5.  Mass spectrometry imaging, an emerging technology in neuropsychopharmacology.

Authors:  Mohammadreza Shariatgorji; Per Svenningsson; Per E Andrén
Journal:  Neuropsychopharmacology       Date:  2013-08-21       Impact factor: 7.853

6.  Imaging mass spectrometry with silver nanoparticles reveals the distribution of fatty acids in mouse retinal sections.

Authors:  Takahiro Hayasaka; Naoko Goto-Inoue; Nobuhiro Zaima; Kamlesh Shrivas; Yukiyasu Kashiwagi; Mari Yamamoto; Masami Nakamoto; Mitsutoshi Setou
Journal:  J Am Soc Mass Spectrom       Date:  2010-04-24       Impact factor: 3.109

7.  Medical molecular morphology with imaging mass spectrometry.

Authors:  Yoshishige Kimura; Koji Tsutsumi; Yuki Sugiura; Mitsutoshi Setou
Journal:  Med Mol Morphol       Date:  2009-09-26       Impact factor: 2.309

Review 8.  Imaging mass spectrometry for visualization of drug and endogenous metabolite distribution: toward in situ pharmacometabolomes.

Authors:  Yuki Sugiura; Mitsutoshi Setou
Journal:  J Neuroimmune Pharmacol       Date:  2009-06-11       Impact factor: 4.147

9.  The detection of glycosphingolipids in brain tissue sections by imaging mass spectrometry using gold nanoparticles.

Authors:  Naoko Goto-Inoue; Takahiro Hayasaka; Nobuhiro Zaima; Yukiyasu Kashiwagi; Mari Yamamoto; Masami Nakamoto; Mitsutoshi Setou
Journal:  J Am Soc Mass Spectrom       Date:  2010-08-10       Impact factor: 3.109

10.  Dual-polarity SALDI FT-ICR MS imaging and Kendrick mass defect data filtering for lipid analysis.

Authors:  Wendy H Müller; Alexandre Verdin; Christopher Kune; Johann Far; Edwin De Pauw; Cedric Malherbe; Gauthier Eppe
Journal:  Anal Bioanal Chem       Date:  2020-10-30       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.